Effects of the selective oestrogen receptor modulator - Raloxifene - On calcium and PTH secretory dynamics in women with osteoporosis

Clinical Endocrinology

Volumn 54, Issue 5, 2001, Pages 575-582

  Oleksik, A ^a   Duong, T ^b   Popp Snijders, C ^a   Pliester, N ^a   Asma, G ^a   Lips, P ^a,c  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM GLUBIONATE; EDETIC ACID; ESTROGEN RECEPTOR; PARATHYROID HORMONE; RALOXIFENE;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY MASS; BONE MASS; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; FEMALE; HOMEOSTASIS; HORMONE RELEASE; HUMAN; LINEAR REGRESSION ANALYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; CALCIUM; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; EDETIC ACID; FEMALE; HOMEOSTASIS; HUMANS; INFUSIONS, INTRAVENOUS; LINEAR MODELS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0035724708     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01263.x     Document Type: Article

References (44)

1. The effects of menopause and estrogen therapy on the renal handling of calcium
2. Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal post-menopausal women
3. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue
4. Effects of estrogen on circulating 'free' and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in post-menopausal women
5. Hysteresis in the relationship between serum ionized calcium and intact parathyroid hormone during recovery from induced hyper- and hypocalcemia in normal humans
6. Effects of estrogen on response to edetic acid infusion in post-menopausal osteoporotic women
7. The effects of raloxifene on risk of breast cancer in post-menopausal women
8. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in post-menopausal women
9. Estrogen effects on calcitriol levels in post-menopausal women: A comparison of oral versus transdermal administration
10. Effects of estradiol and progesterone on parathyroid hormone secretion from human parathyroid tissue
11. Reduction of vertebral fracture risk in post-menopausal women with osteoporosis treated with raloxifene
12. Long-term estrogen replacement therapy prevents bone loss and fractures
13. Effects of gonadal suppression on the regulation of parathyroid hormone and 1,25-dihydroxyvitamin D secretion in women
14. Effect of estrogen on calcium absorption and serum vitamin D metabolites in post-menopausal osteoporosis
15. Rate and concentration dependence of parathyroid hormone dynamics during stepwise changes in serum ionized calcium in normal humans
16. Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis
17. Skeletal responsiveness to parathyroid hormone in healthy females, relationship to menopause and estrogen replacement
18. Estrogen via estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation
19. Age and menopause related changes in indices of bone turnover
20. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-based study
21. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3
22. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption
23. Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-1-34): Kinetics and biochemical response in estrogenized osteoporotic patients
24. Stimulation and suppression of intact parathyroid hormone (PTH1-84) in normal subjects and hyperparathyroid patients
25. Treatment of established post-menopausal osteoporosis with raloxifene: A randomized trial
26. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause - A clinical research center study
27. Estrogen receptors and biologic response in rat parathyroid tissue and C cells
28. Biochemical variables in pre- and post-menopausal women: Reconciling the calcium and estrogen hypotheses
29. Parathyroid hormone clearance in man
30. Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women
31. Bone histomorphometric results of a two-year randomized, placebo controlled trial of raloxifene in post-menopausal women
32. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in post-menopausal women
33. Study of parathyroid function in man by EDTA infusion
34. The effect of estrogen on water and electrolyte metabolism. I. The normal
35. Effects of transdermal estrogen replacement on parathyroid hormone secretion
36. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women
37. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in post-menopausal women with angina pectoris and normal results on coronary angiograms
38. Summary of equations and formulas
39. Episodic secretion of parathyroid hormone in post-menopausal women: Assessment by deconvolution analysis and approximate entropy
40. Calcium supplementation suppresses bone resorption in early post-menopausal women
41. Calcitonin and the calcium-regulating hormones in post-menopausal women: Effects of estrogens
42. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women
43. Effect of estrogen status on bone regulating hormones
44. Does estrogen replacement therapy influence parathyroid hormone responsiveness to exogenous hypercalcemia in post-menopausal women?